Monte Rosa Therapeutics, Inc. GLUE reported Phase 1 trial results for its inflammatory disease drug candidate MRT-8102, while ...
The experimental weight-loss drug is a triple agonist and the first of its kind to reach a phase 3 clinical trial ...
Akums Drugs & Pharmaceuticals has received India’s drug regulator’s approval for Colchicine 0.5 mg tablets, marking a ...
GLP-1 weight-loss results vary widely, and eating patterns may help explain why some patients lose more weight than others.
Metformin is the most prescribed diabetes medication worldwide and has recently been attracting intense attention from the ...
A reporting trip to a sauna conference in Oslo found NPR's Will Stone in a sauna with his clothes and recording gear. In this reporter's notebook, he explains how he investigates the science behind ...
Hello everyone!I am Hosuke Kaya.The series "Drugs and Psychiatry" which I started the year before last, has now reached its ...
A study of 1.4 million adults in England found that more than one-third had high blood pressure, while nearly two-thirds were unaware they had it. A person can have blood pressure high enough to meet ...
The 50-page document outlines what the FDA would like to see as vendors submit their technologies for regulatory review. It ...
Spread the loveWhen it comes to weight loss, we’ve seen a lot of promises, a lot of fads, and a lot of disappointment. But ...
Continuous cerebrospinal fluid sampling confirmed high CNS exposure, with a Kp,uu of 1.9BOSTON, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Rezera Inc.
Roche Holding (SWX:ROP) announced new R&D alliances focused on AI-powered therapeutics and metabolic disease programs in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results